Avantor Penned An Agreement With Tobin Scientific To Support Biopharma Customers Looking To Relocate Their Labs, Research Facilities, And Samples
Portfolio Pulse from Benzinga Newsdesk
Avantor, Inc. (NYSE:AVTR) has entered into an agreement with Tobin Scientific to support biopharma customers in relocating their labs, research facilities, and samples. The partnership aims to meet the growing need for complex logistics solutions with temperature-specific requirements in the biopharma industry.
September 07, 2023 | 11:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avantor's partnership with Tobin Scientific could enhance its service offerings and potentially increase its customer base in the biopharma industry.
The partnership with Tobin Scientific allows Avantor to provide a more comprehensive service to its biopharma customers, potentially attracting more clients and increasing revenues. However, the financial impact will depend on the success of the partnership and the demand for these services.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100